Google
Trusted Resources: News & Meetings
Latest announcements and gatherings
XIX ISA Symposium on Amyloidosis 2024
This symposium is organized as a hybrid meeting (with the focus on in-person) held from Sunday, May 26 through Thursday, May 30, 2024.
Together with the ISA Board and members of the Mayo Clinic, a very attractive scientific hybrid program is being planned. The program will cover a variety of types of systemic amyloidosis: ATTR (hereditary and wild-type), AL (light-chain), AA and less frequent forms. There will be key lectures, specific symposia including those company sponsored, oral presentations and poster sessions of accepted abstracts.
30 Civic Center Drive SE
Rochester, Minnesota, USA
myBinderRelated Content
-
Muzaffar H. Qazilbash, MDMuzaffar Qazilbash is a Professor of med...
-
Wild Type Transthyretin Amyloidosis (ATTRwt): An OverviewWild-type ATTR is also referred to as AT...
-
The Patient Journey Toward a Diagnosis of Hereditary Transthyretin (ATTRv) AmyloidosisBackground: Despite emerging treatments...
-
Current AL Amyloidosis Treatmentshttps://www.youtube.com/watch?v=-E3rKtBE...
-
Plasma Cell Antibodies – ASG Webinar 6/13https://www.youtube.com/watch?v=4gUXPbOk...
-
Management of Systemic AL Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific...Systemic AL amyloidosis is a plasma cell...
-
Stanford Amyloid Center: Kevin Anderson’s Storyhttps://www.youtube.com/watch?v=rfl0xWzg...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
